ArticleJournal of robotic surgery2026
Prospective comparison of robotic versus laparoscopic one-anastomosis gastric bypass: real-life analysis of procedural standardization and safety during the initial adoption phase.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adoption of robotic One-Anastomosis Gastric Bypass (rOAGB) is increasing, yet comparative data with the established laparoscopic approach remain limited. This study evaluates the initial adoption phase of rOAGB by a single surgeon, focusing on procedural consistency and safety compared to a laparoscopic (LAP) team. We prospectively analyzed 135 consecutive patients undergoing primary OAGB between October 2024 and October 2025. 81 LAP procedures (LAP group) were compared to 54 robotic procedures (rOAGB group). The rOAGB cohort represented the first series of this specific procedure for a surgeon experienced in other robotic platforms. The primary endpoint was procedural standardization, measured by operative time (OT) variance. Secondary endpoints included 30-day morbidity. The rOAGB series was chronologically divided into two six-month periods based on the study's one-year duration. This temporal split resulted in an equal distribution of cases (27 procedures per semester). Baseline characteristics were comparable (p > 0.05). LAP was significantly faster (mean OT 86.0 ± 26.6 min vs. 96.8 ± 20.8 min; p = 0.004). However, rOAGB demonstrated a significantly narrower distribution of OTs (SD 20.8 vs. 26.6). In the rOAGB cohort, an F-test revealed a significant reduction in OT variance between the first and second semester of activity (p = 0.0134), indicating rapid stabilization. 30-day complication rates were similar (1.2% LAP vs. 3.7% rOAGB; p = 0.56). While LAP surgery remains faster, the robotic platform facilitates superior procedural consistency during the adoption phase. The robotic approach achieved significant standardization within 27 cases, maintaining a safety profile comparable to the established LAP technique.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.